Skip to main content
. 2020 May 5;20:381. doi: 10.1186/s12885-020-06854-w

Fig. 1.

Fig. 1

Flow diagram demonstrating the methods used to identify studies to retrospectively evaluate the efficacy and safety of cisplatin-based chemotherapy with or without bevacizumab (BEV) in Chinese women with advanced cervical cancer (ACC)